Navigation Links
Collagen Matrix, Inc. Launches OssiMend(TM) Bone Graft Matrix for Orthopedic and Spine Applications

FRANKLIN LAKES, N.J., Oct. 23 /PRNewswire/ -- Collagen Matrix, Inc. announces the launch of its OssiMend(TM) Bone Graft Matrix for orthopedic and spine applications. OssiMend is an all-natural mineral-collagen composite bone graft material which, combined with autologous bone marrow, is used to fill bony voids or gaps of the skeletal system, including spine, extremities and pelvis. OssiMend is conformable, non-friable, has a high absorption capacity, and is ideal for use in spine fusion procedures.

OssiMend is a composite matrix available in strips, pads, or granular form for surgical implantation. The principle components of OssiMend are type I collagen and anorganic bone mineral. The natural anorganic bone mineral is derived from bovine cancellous and cortical bone. Due to its natural structure, OssiMend is physically and chemically comparable to the mineralized matrix of human bone. The mineral particles are dispersed within highly purified type I collagen fibers forming a three-dimensional open porous matrix for use as an osteoconductive material. The addition of autologous bone marrow further enhances the bone forming capability of the product from bone inductive factors and bone forming cells in the bone marrow. OssiMend is provided as a sterile, dry material that is hydrated with autologous bone marrow at the point of use. OssiMend strips and pads can be cut into shapes and are designed to retain their shape and physical integrity following implantation into a bony site, while the granular form can be molded to fit the bone defect. The product is fully resorbed during the natural process of bone formation and remodeling.

"Early launch sales of OssiMend via independent sales agents have been better than expected. Feedback from surgeons has been very positive, therefore we are enthusiastic about the official launch of OssiMend at this year's North American Spine Society meeting, October 24-26, Austin, TX. Along with OssiMend, we are introducing a Multi-port Bone Marrow Aspiration Needle to aid in the harvest of autologous bone marrow. Additional products for the orthopedic-spine market, including OssiGuide(TM) Anorganic Bone Mineral Granules and DuraMatrix-Spine Onlay(TM), are planned for commercialization in the next several months." said Shu-Tung Li, Ph.D., Founder and CEO, Collagen Matrix.

About Collagen Matrix, Inc.

A Franklin Lakes, NJ based, privately-held, leading collagen- and mineral- based biomaterials company, Collagen Matrix, Inc. has applied its expertise in proprietary matrix engineering to develop and commercialize novel implants for tissue and organ repair and regeneration. The Company currently manufactures collagen- and mineral-based finished medical devices in areas of oral surgery, neurosurgery, orthopedic-spine surgery, and wound care. Over 20 products are currently being marketed directly or through partnerships with some of the world's major medical device companies. In addition to OssiMend, Collagen Matrix's marketed products include: DuraMatrix(TM) for dural repair, Neuroflex(TM), NeuroMatrix(TM) for peripheral nerve repair, Collagen Dental Membrane, Anorganic Bone Mineral, and SynOss(TM) for oral bone repair and augmentation, and the Matrix Collagen Family of Products for wound care. For more information, visit

Contact: Shu-Tung Li, PHD, 201-405-1477, 888-405-1001

SOURCE Collagen Matrix, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Scientists find way to make human collagen in lab
2. Merge launches diagnostic mammography workstation in Europe
3. Einstein Wireless launches cellular alert system
4. Logistics Health launches compliance management tool
5. UW-Madison launches new high-speed research network
6. UWM launches research foundation
7. TeraMedica launches information manager
8. GE Healthcare launches hybrid electronic record
9. Cedara launches new version of DICOM toolkit
10. Merge launches Spanish version of imaging tool
11. Doyle launches 2025 alternative energy plan
Post Your Comments:
(Date:6/27/2016)... NC (PRWEB) , ... June 27, 2016 , ... ... just published their findings on what they believe could be a new and ... of the new research. Click here to read it now. , ...
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... , June 24, 2016  Regular discussions on a range ... place between the two entities said Poloz. Speaking ... Ottawa , he pointed to the country,s inflation ... federal government. "In ... "Both institutions have common economic goals, why not sit down ...
Breaking Biology Technology:
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):